A Study of Duvelisib in Combination With Rituximab and Bendamustine vs Placebo in Combination With Rituximab and Bendamustine in Subjects With Previously-Treated Indolent Non-Hodgkin Lymphoma (BRAVURA)

Clinical trial NCT02576275 · WITHDRAWN

Trial details

NCT number: NCT02576275
Sponsor: SecuraBio
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Indolent Non-Hodgkin's Lymphoma Follicular Lymphoma Small Lymphocytic Lymphoma Marginal Zone Lymphoma

Start date: 2015-12-01
Primary completion: 2016-11-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.